The heart medicine known as digoxin or digitalis made by Actavis Totowa LLC is being recalled by the FDA. Actavis Totowa, a division of Actavis Group, is initiating a Class I nationwide recall of Bertek, UDL & DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. Actavis manufactures the products for Mylan and the products are distributed by Mylan and UDL under the Bertek and UDL labels. Bertek and UDL are affiliates of Mylan.

The voluntary recall of UDL Digoxin includes all lots, due to the possibility that UDL Digoxin tablets were made with double the appropriate thickness may have been commercially released. These UDL Digoxin tablets may contain twice the approved level of active ingredient than it appropriate which can result in digitalis toxicity, nausea, vomiting, dizziness, low blood pressure, cardiac instability, bradycardia and death. (see: UDL Digoxin Side Effects) BertekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength UDL Digoxin tablets poses a risk of digitalis toxicity in patients with renal failure

UDL Digoxin Lawsuits - Contact a UDL Digoxin Lawyer

If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of UDL Digoxin, please call us immediately for a Free UDL Digoxin Recall Lawsuit Evaluation at 1-800-883-9858.

Nationwide Help is Available